SEARCH

SEARCH BY CITATION

References

  • 1
    Yssel H & Groux H. Characterization of T cell subpopulations involved in the pathogenesis of asthma and allergic diseases. Int Arch Allergy Immunol 2000; 121:108.
  • 2
    Marone G. Asthma: recent advances. Immunol Today 1998; 19:59.DOI: 10.1016/s0167-5699(97)01187-0
  • 3
    Kaminuma O, Mori A, Ogawa K et al. Cloned Th cells confer eosinophilic inflammation and bronchial hyperresponsiveness. Int Arch Allergy Immunol 1999; 118:1369.
  • 4
    KleinJanuary A, Dijkstra MD, Boks SS, Severijnen LA, Mulder PG, Fokkens WJ. Increase in IL-18, IL-10, IL-13, and RANTES mRNA levels (in situ hybridization) in the nasal mucosa after nasal allergen provocation. J Allergy Clin Immunol 1999; 103:44150.
  • 5
    De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG. Interleukin-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen presenting capacity of monocytes via down-regulation of class II major histocompatibility complex expression. J Exp Med 1991; 174:91524.
  • 6
    Tournoy KG, Kips JC, Pauwels RA. Endogenous interleukin-10 suppresses allergen-induced airway inflammation and nonspecific airway responsiveness. Clin Exp Allergy 2000; 30:77583.DOI: 10.1046/j.1365-2222.2000.00838.x
  • 7
    De Vries JE. The role of IL-13 and its receptor in allergy and inflammatory responses. J Allergy Clin Immunol 1998; 102:1659.
  • 8
    Wills-Karp M, Luyimbazi J, Xu X et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:225863.
  • 9
    Luttmann W, Matthiesen T, Matthys H, Virchow JC. Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-α on eosinophil activation in vitro. Am J Respir Cell Mol Biol 1999; 20:47480.
  • 10
    Dinarello CA. IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol 1999; 103:1124.
  • 11
    Dao T, Ohashi K, Kayano T et al. Interferon γ-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells. Cell Immunol 1997; 173:2305.DOI: 10.1006/cimm.1996.0272
  • 12
    Kumano K, Nakao A, Nakajima H et al. Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways. Am J Respir Crit Care Med 1999; 160:8738.
  • 13
    Wild JS, Sigounas A, Sur N et al. IFN-γ inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma. J Immunol 2000; 164:270110.
  • 14
    Aarvak T, Chabaud M, Miossec P, Natvig JB. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999; 162:124651.
  • 15
    Fossiez F, Banchereau J, Murray R et al. T cell interleukin-17 induces stroma cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 1996; 183:2593603.
  • 16
    Fossiez F, Banchereau J, Murray R et al. Interleukin-17. Int Rev Immunol 1998; 16:54151.
  • 17
    American Thoracic Society. Guidelines for the evaluation of impairment/disability in patients with asthma. Am Rev Respir Dis 1993; 147:105661.
  • 18
    American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995; 152:110736.
  • 19
    Lam KK, Pang SC, Allan WG et al. Predictive normograms for forced expiratory volume, forced vital capacity, and peak expiratory flow rate, in Chinese adults and children. Br J Dis Chest 1983; 77:3906.
  • 20
    National Heart, Blood and Lung Institute. Expert Panel Report 2: guidelines for the management of asthma, publication no. 97–4051. Bethesda, MD: National Institutes of Health, 1997.
  • 21
    National Heart, Blood and Lung Institute. Global strategy for asthma management and prevention. WHO/NHLBI workshop report, publication no. 95–3659. Bethesda, MD: National Institutes of Health, 1995.
  • 22
    Lam CWK, Fung HK, Vrijmoed LLP et al. Aetiology of allergic rhinitis in Hong Kong. Allergo Int 1998; 47:238.
  • 23
    Leung R, Ho P, Lam CWK, Lai CKW. Sensitisation to inhalant allergens as a risk factor for asthma and allergic diseases in Chinese. J Allergy Clin Immunol 1997; 99:5949.
  • 24
    Akahoshi M, Nakashima H, Tanaka Y et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum 1999; 42:16448.
  • 25
    Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:80617.
  • 26
    Synek M, Beasley R, Frew AJ et al. Cellular infiltration of the airways in asthma of varying severity. Am J Respir Crit Care Med 1996; 154:22430.
  • 27
    Cho SH, Seo JY, Choi DC et al. Pathological changes according to the severity of asthma. Clin Exp Allergy 1996; 26:12109.
  • 28
    Zimmerman B, Lanner A, Enander I, Zimmerman RS, Peterson CGB, Ahlstedt S. Total blood eosinophils, serum eosinophil cationic protein and eosinophil protein X in childhood asthma: relation to disease status and therapy. Clin Exp Allergy 1993; 23:56470.
  • 29
    Kunkel G & Ryden AC. Serum eosinophil cationic protein (ECP) as a mediator of inflammation in acute asthma, during resolution and during the monitoring of stable asthmatic patients treated with inhaled steroids according to a dose reduction schedule. Inflamm Res 1999; 48:94100.DOI: 10.1007/s000110050425
  • 30
    Lauw FN, Dekkers PE, Te Velde AA et al. Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 1999; 179:64652.DOI: 10.1086/314636
  • 31
    Dinarello CA. Role of pro- and anti-inflammatory cytokines during inflammation: experimental and clinical findings. J Biol Regul Homeost Agents 1997; 11:91103.
  • 32
    Dinarello CA. Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme. Ann NY Acad Sci 1998; 856:111.
  • 33
    Hoshino T, Wiltrout RH, Young HA. IL-18 is a potent coinducer of IL-13 in NK and T cells: a new potential role for IL-18 in modulating the immune response. J Immunol 1999; 162:50707.
  • 34
    Hoshino T, Yagita H, Ortaldo JR, Wiltrout RH, Young HA. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 2000; 30: 19982006.DOI: 10.1002/1521-4141(200007)30:7<1998::aid-immu1998>3.0.co;2-u
  • 35
    Yoshimoto T, Tsutsui H, Tominaga K et al. IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils. Proc Natl Acad Sci 1999; 96:139626.
  • 36
    Albanesi C, Scarponi C, Cavani A, Federici M, Nasorri F, Girolomoni G. Interleukin-17 is produced by both Th1 and Th2 lymphocytes, and modulates interferon-gamma- and interleukin-4-induced activation of human keratinocytes. J Invest Dermatol 2000; 115:817.DOI: 10.1046/j.1523-1747.2000.00041.x
  • 37
    Robinson DS, Tsicopoulos A, Meng Q, Durham S, Kay AB, Hamid Q. Increased interleukin-10 messenger RNA expression in atopic allergy and asthma. Am J Respir Cell Mol Biol 1996; 14:1137.
  • 38
    Borish L, Aarons A, Rumbyrt J, Cvietusa P, Negri J, Wenzel S. Interleukin-10 regulation in normal subjects and patients with asthma. J Allergy Clin Immunol 1996; 97:128896.
  • 39
    Koulis A & Robinson DS. The anti-inflammatory effects of interleukin-10 in allergic disease. Clin Exp Allergy 2000; 30:74750.DOI: 10.1046/j.1365-2222.2000.00839.x
  • 40
    Hobbs K, Negri J, Klinnert M, Rosenwasser LJ, Borish L. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158:195862.
  • 41
    Prieto J, Lensmar C, Roquet A et al. Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations. Respir Med 2000; 94:80614.DOI: 10.1053/rmed.2000.0826
  • 42
    Robinson D, Hamid Q, Bentley A, Ying S, Kay AB, Durham SR. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J Allergy Clin Immunol 1993; 92:31324.
  • 43
    Ohta K & Yamashita N. Apoptosis of eosinophils and lymphocytes in allergic inflammation. J Allergy Clin Immunol 1999; 104:1421.
  • 44
    Kankaanranta H, Lindsay M, Giembycz MA, Zhang X, Moilanen E, Barnes PJ. Delayed eosinophil apoptosis in asthma. J Allergy Clin Immunol 2000; 106:7783.
  • 45
    Simon HU & Yousefi S. Expansion of cytokine-producing CD4–CD8 T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996; 183:107182.
  • 46
    Fukuda T, Fukushima Y, Numao T et al. Role of interleukin-4 and vascular cell adhesion molecule-1 in selective eosinophil migration into the airways in allergic asthma. Am J Respir Cell Mol Biol 1996; 14:8494.